TG Therapeutics (TGTX)
(Delayed Data from NSDQ)
$23.19 USD
+0.12 (0.52%)
Updated Sep 12, 2024 04:00 PM ET
3-Hold of 5 3
D Value C Growth C Momentum D VGM
Earnings News For TGTX
-
TG Therapeutics: Q2 Earnings Snapshot
-
TG Therapeutics (TGTX) Surpasses Q2 Earnings and Revenue Estimates
-
TG Therapeutics Reports Second Quarter 2024 Financial Results and Raises BRIUMVI? (ublituximab-xiiy) Full Year Revenue Guidance
-
TG Therapeutics: Q1 Earnings Snapshot
-
TG Therapeutics (TGTX) Reports Q1 Loss, Tops Revenue Estimates
-
TG Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results
-
TG Therapeutics: Q4 Earnings Snapshot
-
TG Therapeutics: Q4 Earnings Snapshot
-
TG Therapeutics (TGTX) Reports Q4 Loss, Tops Revenue Estimates
-
TG Therapeutics Provides Business Update and Reports Fourth Quarter and Year-End 2023 Financial Results
-
Will TG Therapeutics (TGTX) Report Negative Q4 Earnings? What You Should Know
-
TG Therapeutics: Q3 Earnings Snapshot
-
TG Therapeutics Provides Business Update and Reports Third Quarter 2023 Financial Results
-
TG Therapeutics (TGTX) Reports Q2 Loss, Tops Revenue Estimates
-
TG Therapeutics: Q2 Earnings Snapshot
-
TG Therapeutics Provides Business Update and Reports Second Quarter 2023 Financial Results
-
TG Therapeutics (TGTX) Reports Q1 Loss, Tops Revenue Estimates
-
TG Therapeutics: Q1 Earnings Snapshot
-
TG Therapeutics Provides Business Update and Reports First Quarter 2023 Financial Results
-
TG Therapeutics (TGTX) Reports Q4 Loss, Tops Revenue Estimates
-
TG Therapeutics: Q4 Earnings Snapshot
-
TG Therapeutics Provides Business Update and Reports Fourth Quarter and Year-End 2022 Financial Results
-
TG Therapeutics (TGTX) Reports Q3 Loss, Lags Revenue Estimates
-
TG Therapeutics: Q3 Earnings Snapshot
-
TG Therapeutics Provides Business Update and Reports Third Quarter 2022 Financial Results